INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

As of April 19, 2024, INO stock price declined to $9.68 with 338,769 million shares trading.

INO has a beta of 1.64, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.04 to the broad based SPY ETF.

INO has a market cap of $226.23 million. This is considered a Small Cap stock.

Last quarter Inovio Pharmaceuticals reported $103,000 in Revenue and -$1.10 earnings per share. This fell short of revenue expectation by $-237,000 and exceeded earnings estimates by $.17.

In the last 3 years, INO stock traded as high as $123.96 and as low as $3.89.

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, VHT, AVSC, GERM.

INO has underperformed the market in the last year with a price return of -8.5% while the SPY ETF gained +21.2%. However, in the short term, INO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +19.6% vs +3.0% return in SPY. But in the last 2 weeks, INO shares have been beat by the market, returning -17.9% compared to an SPY return of -4.5%.

INO support price is $9.53 and resistance is $10.88 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO stock will trade within this expected range on the day.